Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.
Posted 21 February 2012 | By Alexander Gaffney, RAC
The US Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH) has released an updated schedule describing the classification timelines of 26 device classes.
The 17 February release of the schedule is a part of CDRH's 515 Program Initiative, which is part of CDRH's overall Transparency Initiative. The 515 Program is named after Section 515 of the Federal Food, Drug and Cosmetic Act (FD&C Act) which covers the reclassification of medical devices, and seeks to provide transparency in the development of new medical device risk classifications.
As of 2009, 26 medical devices were awaiting final classification. There are currently 22 device classes in various stages of classification development. FDA has collected existing information on all 22 device classes, leaving 15 device classes at a benefit:risk assessment stage, one device class at a proposed rule stage and six device classes at in a post-proposed rule stage awaiting comment.
Tags: Program 515, Reclassification, Classification, Project 515, Transparency Initiative, Latest News, development